Laura R. Brothers

Member

Nashville

(615) 742-7705

lbrothers@bassberry.com

https://www.bassberry.com/professionals/brothers-laura-r/

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.

vCard

With more than 20 years of experience, Laura Brothers leverages her experience in capital markets transactions to help clients raise capital through debt and equity markets, or through strategic acquisitions, navigating complicated securities law issues. Of note, her experience includes offerings of an aggregate of $3.85 billion in the last five years alone for one of the leading retailers and distributors of automotive replacement parts and accessories in the Americas and a $3.8 billion merger of two national health insurance providers.

Laura has represented both issuers and underwriters in securities transactions, buyers and sellers in public and private company mergers and acquisitions and special committees of boards of directors in corporate governance matters. Her practice spans industries including healthcare, technology, retail and entertainment, and involves:

Capital Markets – Advising companies and underwriters in debt and equity transactions, including IPOs, follow-on offerings, and Rule 144A and institutional private placements as well as in transactional matters.
Mergers & Acquisitions – Representing a variety of public and private companies on a wide variety of transactions, including tender offers.
Securities Law Compliance – Advising public company clients on preparation of Form 10-Ks, 10-Qs, 8-Ks, proxy statements and earnings releases; compliance with federal securities laws requirements; compliance with stock exchange listing standards and corporate governance guidelines.
Corporate Governance – Providing clients with advice related to compliance with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Act and other federal securities laws requirements; compliance with stock exchange corporate governance listing standards, committee charters and corporate governance guidelines, board and committee composition issues, internal control and disclosure control matters, Regulation FD, insider trading policies and 10b5-1 trading plans.

In addition to Laura’s work in the firm’s corporate and securities practice, she also chaired the firm’s Women’s Initiative in 2009 and 2010, the Entry-Level Hiring Committee from 2011 to 2013 and also served on the firm’s Diversity Committee.

Memberships

American Health Law Association (AHLA)

Valparaiso University Alumni Association — Board of Directors (2003-2010); Executive Committee, (2005-2010)

Representative Experience

OptionOne Sells to Amerita

Representation of OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care, in its sale to Amerita, Inc., a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. Terms of the transaction were not disclosed.

We represented OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care,...

Read More
Client Type: Private Company
AutoZone August 2020 Notes Offering

Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $600,000,000 of 1.650% Senior Notes due 2031.

We represented AutoZone, Inc. in a public offering of $600,000,000 of 1.650% Senior Notes due 2031. Underwriters included J.P. Morgan...

Read More
Client Type: Public Company
BioMatrix Acquires City Drugs

Representation of BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition of City Drugs, a New York City-based specialty pharmacy that specializes in the treatment of complex medical conditions including hepatitis, oncology, auto-immune diseases, and gastroenterology. Terms of the transaction were not disclosed.

We represented BioMatrix Specialty Pharmacy, a comprehensive, nationwide specialty pharmacy services and digital health technology solutions provider, in its acquisition...

Read More
Client Type: Private Company
VSS and NewSpring Health Capital Invests in BRC Recovery

Representation of BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital

We represented BRC Recovery in its recapitalization with private investment firms, Veronis Suhler Stevenson (VSS) and NewSpring Health Capital. BRC...

Read More
Client Type: Private Company
AutoZone 2020 Notes Offering

Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...

Read More
Client Type: Public Company
2019 Ryman Hospitality Refinancing Transactions

Represented of Ryman Hospitality Properties, Inc. (NYSE: RHP) in various refinancing transactions in September and October 2019, which successfully refinanced almost $2 billion in indebtedness

We represented Ryman Hospitality Properties, Inc. (NYSE: RHP) in various refinancing transactions in September and October 2019, which successfully refinanced...

Read More
Client Type: Public Company
AutoZone 2019 Notes Offering

Representation of AutoZone, Inc. in a public offering of $300,000,000 of 3.125% senior notes due 2024 and $450,000,000 of 3.75% senior notes due 2029.

We represented AutoZone, Inc. in a public offering of $300,000,000 of 3.125% senior notes due 2024 and $450,000,000 of 3.75%...

Read More
Client Type: Public Company
Tennessee Oncology and General Atlantic Create OneOncology

We represented Tennessee Oncology in the launch of OneOncology in affiliation with global private equity firm General Atlantic. OneOncology is...

Read More
Client Type: Private Company
AutoZone April 2017 Notes Offering

We represented AutoZone, Inc. in a public offering of $600,000,000 of 3.750% senior notes due 2027. Underwriters included J.P. Morgan...

Read More
Client Type: Public Company
AmSurg Corp Merges with Envision Healthcare

Represented AmSurg Corp. (NASDAQ: AMSG) in its merger with Envision Healthcare Holdings, Inc. (NYSE: EVHC)

We represented AmSurg Corp. (NASDAQ: AMSG) in its merger with Envision Healthcare Holdings, Inc. The combination of Envision Healthcare and AMSURG...

Read More
Client Type: Public Company

Media Mentions & Firm News

Bass, Berry & Sims Announced as Winner in Two Categories at the 18th Annual M&A Advisor Awards

December 3, 2019

Accolades

Valparaiso University Alumni Association — Alumni Service Award (2011)

Nashville Area Junior Chamber of Commerce — Legal Counsel (1999-2000)

Presidential Scholar

Laura R. Brothers

Notice

Memberships

Representative Experience

Media Mentions & Firm News

Accolades

Education

Admissions

Laura R. Brothers

Notice

Memberships

Representative Experience

Media Mentions & Firm News

Accolades

Related Services

Education

Admissions